Active Ingredient History

  • Now
Fispemifene is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group that was developed for the treatment of male hypogonadism but was abandoned and never marketed. It reached phase II clinical trials for this indication before development was terminated in March 2016. The drug failed to achieve statistical significance on key effectiveness endpoints in clinical trials and was discontinued by its developer for strategic reasons.   Wikipedia

  • SMILES: OCCOCCOc1ccc(cc1)\C(=C(\CCCl)/c2ccccc2)\c3ccccc3
  • Mol. Mass: 422.95
  • ALogP: 5.66
  • ChEMBL Molecule:
More Chemistry
fispemifene | hm-101 | hm-101a | (z)-2-(2-(4-(4-chloro-1,2-diphenylbut-1-enyl)phenoxy)ethoxy)ethanol


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue